~~<i id='36D31E581A'><strike id='36D31E581A'><tt id='36D31E581A'><pre id='36D31E581A'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

explore

author：entertainment 2025-10-01 12:36:04 - browse：46

Adam's take main illustration — Molly Ferguson/STAT

I was wrong about Geron.

For years, I’ve believed — and declared publicly — that Geron’s effort to develop a blood cancer drug called imetelstat would end in disappointment. The drug was never getting approved, I said.

On Thursday, a group of outside experts convened by the Food and Drug Administration voted 12-2 in imetelstat’s favor, concluding the drug’s benefits outweighed its risks for the treatment of patients with myelodysplastic syndrome. The strong endorsement makes an FDA approval highly likely. The decision is expected on or before June 16.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： CDC picks Alphabet's Verily for wasterwater surveillance contract

entertainment

hotspot

entertainment

focus

hotspot

Wikipedia

JeromeDelay/APJusttwoyearsaftertheWorldHealthOrganization’shistoricrecommendationofthefirstmalariava

WSS

Bird flu: Don't repeat Covid's 'health versus the economy' framing

Data integrity in scientific journals requires "effort" by publishers, institutions

Analysis of pharma R&D ranks Novo Nordisk, J&J above their peers

With Roe v Wade overturned, abortion providers work to adapt

Anxious about a speech? A startup wants you to pop a minty cardiac drug

Readout Newsletter: Nvidia, Biogen, Ionis, AstraZeneca, ChatGPT

entertainment

explore

entertainment

Anesthesiologist group: stop taking Ozempic before surgery

RSV injection headlines need to be accurate for good uptake

Psychedelics group wrestles with new pharma identity

Readout Newsletter: Nvidia, Biogen, Ionis, AstraZeneca, ChatGPT

Tori Bowie and the unacceptable rates of Black maternal death

6 solutions to address cancer drug shortages and others

Dobbs anniversary: the lost opportunity of abortion as health care

Glen Campbell's doctor discusses his public struggle with Alzheimer's

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Can we make enough H5N1 bird flu vaccine if there's a pandemic?

hotspot

WHO recommends second malaria vaccine

Bird flu: Don't repeat Covid's 'health versus the economy' framing

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

The biotech scorecard for Q4: 16 stock

Microsoft's Peter Lee says ChatGPT shouldn't be used for initial diagnosis

What we owe ALS patients — and why one company fell short

entertainment

focus

hotspot

Wikipedia